Dosage form comprising a 5-alpha-reductase steroid inhibitor and an alpha blocker, process for the preparation of a dosage form, use of dosage form, method for the treatment or prophylaxis of a disease or condition mediated by androgen
The present invention describes new and improved dosage forms containing a steroid 5-alpha-reductase inhibitor, in combination with an alpha blocker, for the treatment or prophylaxis of an androgen mediated disease or condition, preferably for the treatment of benign prostatic hyperplasia (HPB).